NRXPW

NRX Pharmaceuticals, Inc. - Warrant (NRXPW)

About NRX Pharmaceuticals, Inc. - Warrant (NRXPW)

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.04
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
13,994
P/E ratio
--

NRX Pharmaceuticals, Inc. - Warrant News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.04
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
13,994
P/E ratio
--